An interpretable AI model for recurrence prediction after surgery in gastrointestinal stromal tumour: an observational cohort study

[1]  D. Bertsimas,et al.  Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. , 2022, JAMA Surgery.

[2]  D. Bertsimas,et al.  POTTER-ICU: An artificial intelligence smartphone-accessible tool to predict the need for intensive care after emergency surgery. , 2022, Surgery.

[3]  V. Staartjes,et al.  Foundations of Machine Learning-Based Clinical Prediction Modeling: Part III-Model Evaluation and Other Points of Significance. , 2021, Acta neurochirurgica. Supplement.

[4]  D. Bertsimas,et al.  Validation of the artificial intelligence–based trauma outcomes predictor (TOP) in patients 65 years and older , 2021, Surgery.

[5]  D. Bertsimas,et al.  Toward an Optimized Staging System for Pancreatic Ductal Adenocarcinoma: A Clinically Interpretable, Artificial Intelligence–Based Model , 2021, JCO clinical cancer informatics.

[6]  D. Bertsimas,et al.  Benchmarking in Congenital Heart Surgery Using Machine Learning-Derived Optimal Classification Trees , 2021, World journal for pediatric & congenital heart surgery.

[7]  J. Blay,et al.  Gastrointestinal stromal tumours , 2021, Nature Reviews Disease Primers.

[8]  D. Bertsimas,et al.  Validation of the Artificial Intelligence-Based Predictive Optimal Trees in Emergency Surgery Risk (POTTER) Calculator in Emergency General Surgery and Emergency Laparotomy Patients. , 2021, Journal of the American College of Surgeons.

[9]  D. Bertsimas,et al.  Validation of the Al-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) Calculator in Patients 65 Years and Older , 2020, Annals of surgery.

[10]  Dimitris Bertsimas,et al.  Machine Learning in Oncology: Methods, Applications, and Challenges. , 2020, JCO clinical cancer informatics.

[11]  V. Staartjes,et al.  Significance of external validation in clinical machine learning: let loose too early? , 2020, The spine journal : official journal of the North American Spine Society.

[12]  Mustafa Suleyman,et al.  Key challenges for delivering clinical impact with artificial intelligence , 2019, BMC Medicine.

[13]  D. Bertsimas,et al.  Comparison of Machine Learning Optimal Classification Trees With the Pediatric Emergency Care Applied Research Network Head Trauma Decision Rules. , 2019, JAMA pediatrics.

[14]  Jie Ma,et al.  A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. , 2019, Journal of clinical epidemiology.

[15]  Scott M. Lundberg,et al.  Explainable machine-learning predictions for the prevention of hypoxaemia during surgery , 2018, Nature Biomedical Engineering.

[16]  D. Bertsimas,et al.  Surgical Risk Is Not Linear: Derivation and Validation of a Novel, User-friendly, and Machine-learning-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) Calculator , 2018, Annals of surgery.

[17]  Towards trustable machine learning , 2018, Nature Biomedical Engineering.

[18]  Robin L. Jones,et al.  Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  B. Goh,et al.  Systematic review of current prognostication systems for primary gastrointestinal stromal tumors. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  G. Guyatt,et al.  Discrimination and Calibration of Clinical Prediction Models: Users’ Guides to the Medical Literature , 2017, JAMA.

[21]  Dimitris Bertsimas,et al.  Sparse classification: a scalable discrete optimization perspective , 2017, Machine Learning.

[22]  Dimitris Bertsimas,et al.  Optimal classification trees , 2017, Machine Learning.

[23]  Kathleen F. Kerr,et al.  Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Yvonne Vergouwe,et al.  A calibration hierarchy for risk models was defined: from utopia to empirical data. , 2016, Journal of clinical epidemiology.

[25]  Gary S Collins,et al.  Sample size considerations for the external validation of a multivariable prognostic model: a resampling study , 2015, Statistics in medicine.

[26]  R. Bracci,et al.  Risk stratification systems for surgically treated localized primary Gastrointestinal Stromal Tumors (GIST). Review of literature and comparison of the three prognostic criteria: MSKCC Nomogramm, NIH-Fletcher and AFIP-Miettinen. , 2015, Annali italiani di chirurgia.

[27]  F. Quereshy,et al.  The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors , 2015, Journal of surgical oncology.

[28]  Aki Vehtari,et al.  Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. , 2012, The Lancet. Oncology.

[29]  K. Tanabe,et al.  Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis , 2012, World Journal of Surgical Oncology.

[30]  J. Mandrekar.  Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  C. Antonescu,et al.  Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. , 2009, The Lancet. Oncology.

[32]  H. Joensuu.  Predicting recurrence-free survival after surgery for GIST. , 2009, The Lancet. Oncology.

[33]  C. Antonescu,et al.  Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[34]  A. Vickers.  Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers , 2008, The American statistician.

[35]  H. Joensuu.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor. , 2008, Human pathology.

[36]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[37]  J. Lasota,et al.  Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.

[38]  Yvonne Vergouwe,et al.  Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. , 2005, Journal of clinical epidemiology.

[39]  B. Eisenberg,et al.  Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant Therapy , 2004, Annals of Surgical Oncology.

[40]  Chris H. Q. Ding,et al.  Minimum redundancy feature selection from microarray gene expression data , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.

[41]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[42]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.

[43]  H. Ong,et al.  Validation of the MSKCC Gastrointestinal Stromal Tumor Nomogram and Comparison with Other Prognostication Systems: Single-Institution Experience with 289 Patients , 2015, Annals of Surgical Oncology.

[44]  P. Chow,et al.  Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST ? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk Criteria , 2008 .

[45]  R. DeMatteo,et al.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. , 2000, Annals of surgery.

[46]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .